A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)
Clinical trial NCT04767295 · UNKNOWN
Trial details
- NCT number
- NCT04767295
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.